AI-Based Medical Diagnostic Tools Market Set to Exceed USD 11.5 Billion by 2034: Global Surge in AI Start-up Funding Expands Diagnostic Systems Integration | TMR

AI-powered diagnostic systems deliver precise and efficient diagnoses, enabling healthcare professionals to develop timely and effective treatment plans. This integration of AI extends across various diagnostic tools, including X-rays, enhancing their capabilities on a broader scale.

WILMINGTON, Del., July 17, 2024 /PRNewswire/ — The market for AI-based medical diagnostic tools accounted for US$ 1.3 billion in 2023. A CAGR of 20.8% is expected from 2024 to 2034, culminating in a market value of US$ 11.5 billion by 2034. Medical diagnostic instruments based on AI require ongoing research and development.

In addition to enhancing the efficiency of existing algorithms, this involves investigating new artificial intelligence approaches such as deep learning, reinforcement learning, and federated learning for medical applications.

AI-based diagnostic tools can empower patients by providing them with personalized health information. Smartphone apps and AI-driven health monitoring gadgets can help patients manage their health and well-being more actively.

Medical specialists and facilities are often limited in underserved or distant places, so AI-based diagnostics can be especially helpful. Through the use of portable diagnostic devices and telemedicine platforms, Artificial Intelligence can increase access to healthcare for communities that have limited access to healthcare.

Grab Your Sample Report Here! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=69867

Healthcare systems are expected to incorporate AI-based diagnostic technologies as they advance in sophistication and dependability. This integration may include seamless integration with clinical decision support systems and electronic health records (EHR) in order to speed up diagnosis for healthcare practitioners.

Key Findings of the Market Report

  • AI-based medical diagnostic tools will be created in the market by the software segment.
  • As consumers become more likely to suffer from cancer, demand for oncology AI-based medical diagnostics tools will increase.
  • In 2023, diagnostic laboratories held the largest share of the market.
  • In 2023, North America dominated the market in terms of market share.

Global AI-based Medical Diagnostic Tools Market: Growth Drivers

  • Increasing chronic illness prevalence and an expanding need for accurate and timely diagnosis are two contributing factors. With AI-powered diagnostic tools, health care providers can detect diseases earlier and treat them more effectively, thus improving their accuracy, efficiency, and speed of diagnosis. Diabetes, cancer, and cardiovascular diseases are a few of the chronic diseases that have increased the need for novel diagnostic methods.
  • AI-based diagnostic tools are becoming easier to incorporate into clinical practice as electronic health records (EHRs) become more widely adopted and data access increases.
  • AI algorithms are being assessed and trained using substantial amounts of patient data by healthcare organizations and providers. As a result, diagnostic instruments that are more reliable and beneficial therapeutically are being developed.
  • The healthcare sector is also embracing AI-based diagnostic tools on a larger scale as regulatory agencies become more aware of its potential to improve patient outcomes and reduce healthcare costs.
  • As a result, AI-based medical diagnostics have a lot of potential for improving the accuracy, efficiency, and personalized treatment of patients, so they’re a great fit for the future.

Get a PDF Brochure for Report Overview! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=69867

AI-based Medical Diagnostic Tools Market Report Scope:

Report Coverage

Details 

Forecast Period  

2024-2034

Base Year  

2020-2022

Size in 2023

US$ 1.3 Bn

Forecast (Value) in 2034

US$ 11.5 Bn

Growth Rate (CAGR) 

20.8 %

No. of Pages 

156 Pages 

Segments covered 

By Component, By Application, By Region, By End-user

Global AI-based Medical Diagnostic Tools Market: Regional Landscape

  • Artificial intelligence-based medical diagnostic technologies are undergoing rapid scientific advancements in North America. AI-driven diagnostic technology is gradually being integrated into clinical operations in the area in order to improve patient outcomes and increase productivity.
  • Regulatory agencies like Health Canada and the Food and Drug Administration (FDA) in the United States and Canada approve and oversee medical devices and diagnostic tools. The development of AI-based diagnostics in the future will be influenced by the way these regulatory bodies adapt their approval procedures to take into account the rapidly developing AI technologies while maintaining patient safety and efficacy.
  • In North America, regulatory agencies such as the Food and Drug Administration (FDA) are essential to guaranteeing the security and efficacy of medical diagnostic devices powered by artificial intelligence (AI). To help businesses launch their products while maintaining patient safety and data security, the FDA has set guidelines for the validation and oversight of AI algorithms used in medical diagnostics. Because of this, North America continues to lead the way in AI-driven innovation in medical diagnostics, and further growth and adoption are anticipated.

Global AI-based Medical Diagnostic Tools Market: Competitive Landscape

AI-based medical diagnostic tool companies are expanding their customer bases through inorganic expansion. Brain tumors can be accurately detected by AI-based tools developed by medical diagnostic companies.

Key Players Profiled

  • Microsoft
  • Nvidia Corporation
  • Merative L.P.
  • Alphabet Inc.
  • Intel Corporation
  • Siemens Healthineers
  • GE HealthCare
  • Advanced Micro Devices Inc.
  • Koninklijke Philips N.V.
  • InformAI

Key Developments

  • In October 2023, Microsoft launched new data and artificial intelligence solutions for healthcare organizations to unlock insights and improve patient care.
  • In December 2023, Nvidia launched a series of cloud APIs that accelerate AI model development and deployment for medical imaging applications. Using Nvidia’s open-source Monai framework, the new offering extends Monai with cloud-native capabilities.

Global AI-based Medical Diagnostic Tools Market: Segmentation

By Component

  • Software
  • Services
  • Hardware
  • Memory
  • Others (Network, etc.)

By Application

  • Radiology
  • Cardiology
  • Neurology
  • Oncology
  • Others (Ophthalmology, Gynecology, etc.)

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Others (Ambulatory Surgical Centers, etc.)

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=69867&ltype=S

More Trending Reports by Transparency Market Research –

  • X-ray Detectors MarketThe global market was worth US$ 2.5 Bn and is projected to reach a value of US$ 4.6 Bn by the end of 2031
  • Electronic Health Records (EHR) Market – The global market is forecasted to experience robust growth, reaching over US$ 48.3 billion by 2031, with a projected CAGR of 6.5% from 2023 onwards.
  •  Digital Biomarkers Market: Digital Biomarkers Market is expected to grow at a CAGR of 31.4% from 2024 to 2034 and reach US$ 43.3 Bn by the end of 2034

  • Clinical Data Analytics Market: Clinical Data Analytics Market is expected to grow at a CAGR of 39.7% from 2024 to 2034 and reach US$ 614.7 Bn by the end of 2034

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo: https://healthtechnologynet.com/wp-content/uploads/2024/07/TMR_Logo_Logo-3.jpg

 

View original content:https://www.prnewswire.com/news-releases/ai-based-medical-diagnostic-tools-market-set-to-exceed-usd-11-5-billion-by-2034-global-surge-in-ai-start-up-funding-expands-diagnostic-systems-integration–tmr-302199294.html

SOURCE Transparency Market Research

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago